Press Coverage Biotechnology Industry Organization (BIO)-Pugatch Consilium report on Intellectual Property Rights and emerging and developing economies

Posted by:

A number of media outlets, including Reuters and Yahoo! Finance, are covering the release next week of a new Pugatch Consilium authored report on the role played by IPRs in biotechnology research and development.

Commissioned by BIO the report, titled “Taking Stock: the Gains of Global Biotechnology Research from IPRs,” focuses on the extent to which IPRs play a role in encouraging upstream R&D and downstream commercialization in biotechnology. Significantly it provides evidence and case study analysis of the role of ...

Continue Reading →
0

Pugatch Consilium at BIO 2012

Posted by:

Pugatch Consilium are pleased to announce that we will be presenting the findings of a new research report on IPRs and biotechnology at the 2012 BIO convention in Boston, Massachusetts.

The event, Intellectual Property and Biotechnology – The Way Ahead, will be held on June 19th at 2pm. The session will unveil a new report commissioned by BIO and carried out by Pugatch Consilium. The report focuses on the extent to which intellectual property rights (IPRs) play a role in encouraging upstream ...

Continue Reading →
0

News coverage of Pugatch Consilium report

Posted by:

Last week Pugatch Consilium launched a new report in Geneva, “Assembling the pharmaceutical R&D puzzle for needs in the developing world”. The report examines the opportunities and challenges associated with new and proposed delinking initiatives aimed at supplementing the existing R&D model to encourage R&D into neglected and tropical diseases (NTDs) and specific Type II diseases. It also provides a blueprint for evaluating the effectiveness of such mechanisms based on six key factors for success.

Online coverage of the report includes an Intellectual ...

Continue Reading →
0

EU Directorate General for External Policies and the European Parliament ACTA workshop report released

Posted by:

Earlier this year on March 1 2012 the Directorate General for External Policies and the European Parliament hosted a workshop on the ACTA agreement. Based on his academic work and international expertise in the area of IPRs, international trade and pharmaceuticals, Pugatch Consilium founder and Managing Director Dr Meir Pugatch spoke at the workshop on the ACTA’s potential impact on the international trade of generic medicines.

As part of the workshop Dr Pugatch and Pugatch Consilium Senior Consultant Dr David Torstensson ...

Continue Reading →
0

New Pugatch Consilium report

Posted by:

The Pugatch Consilium has released a new report, “Assembling the pharmaceutical R&D puzzle for needs in the developing world”.

Launched last week in Geneva, the report examines the opportunities and challenges associated with new and proposed delinking initiatives aimed at supplementing the existing R&D model to encourage R&D into neglected and tropical diseases (NTDs) and specific Type II diseases. It also provides a blueprint for evaluating the effectiveness of such mechanisms based on six key factors for success.

To view the full report, ...

Continue Reading →
0

The battle down under becomes global – how far reaching is the impact of Australia’s new plain packaging law?

Posted by:

Tobacco companies are challenging  the constitutionality of a law banning the display of their logos and designs on cigarette packs in Australia’s High Court. Their argument is that by appropriating valuable property – the trademarks which identify and distinguish their products – without compensating them, the government is ‘unjustly’ acquiring property. The debate has already expanded beyond Australia; the UK and New Zealand are also considering similar laws. More broadly, the important question is how such a law – which ...

Continue Reading →
0

Supreme Court Ruling – Prometheus v Mayo

Posted by:

Late last month the United States Supreme Court overturned existing patent claims held by Prometheus Laboratories.

The patents in question relate to a test enabling physicians to set levels of medication for treating autoimmune disorders affecting the digestive system. The Court argued that the patents did not in fact do more than describe naturally occurring phenomena, which in themselves are not patentable.

The verdict has raised concerns in the biotechnology industry over future application of the ruling and its implications for lower ...

Continue Reading →
0

Permission to pin?

Posted by:

The rapid growth of the online curating site, Pinterest, over the last few months – it acquired 17.8 million unique users in February 2012 alone – is raising a handful of issues, including whether online ‘curation’ constitutes ‘fair use’ of online content? The site enables users to collect images, ideas and concepts they encounter on the web and ‘pin’ or curate them on online boards, which other users can view and ‘re-pin’.

Its recent bombardment of new users is bringing front and ...

Continue Reading →
0

Dr Meir Pugatch invited to speak on ACTA and access to medicines by European Parliament

Posted by:

Wide-spread protests against the ACTA in Europe have intensified what was already a heated debate over the treaty and its potential impact in the EU. While protesters have mainly focused on ACTA and the internet, policymakers at both the EU and national level have been examining the treaty’s potential effect on the international trade of generic medicines.

Ensuring access to medicines in middle and low income countries has since the late 1990s been a priority for the international community. The access ...

Continue Reading →
0

ACTA protesters – do they have the wrong target?

Posted by:

The week of February 6, 2012 saw fresh opposition to the ACTA treaty across Europe, including an online petition which received over 2,000,000 signatures and more than 100 protests in major cities on Saturday, February 11. Protesters are calling for the European Parliament to reject the treaty, which they say restricts fundamental rights.

Yet, a thorough look shows that when it comes to the internet, ACTA may not be as radical as critics claim, and that it is the application of ACTA’s principles ...

Continue Reading →
0
Page 12 of 15 «...1011121314...»